Abstract
The biotransformations of artemisinin and artemisinin derivatives leading to metabolites that may serve as prospective candidates for antimalarial evaluation or as starting materials for hemisynthesis of antimalarial derivatives are reviewed, focusing on the preparation of regio- and stereoselectively hydroxylated derivatives still possessing the 1,2,4- trioxane structure that can be used as scaffolds for the production of novel antimalarials with increased water solubility, lower toxicity and decreased potential for resistance. A special emphasis has been also placed on the recent manufacturing of artemisinin and derivatives via microbiological methods, involving cloning and overexpression of biosynthetic enzymes and allowing to design an alternative route for artemisinin production.
Keywords: Arteether, artemether, artesunate, artemisia annua, bacteria, fungi, hydroxylations, synthetic reactions, molecular diversity, microbial generation.
Current Bioactive Compounds
Title:Microbial Transformations of Artemisinin and Artemisinin Derivatives: an Example of the Microbial Generation of Molecular Diversity
Volume: 8 Issue: 2
Author(s): Robert Azerad
Affiliation:
Keywords: Arteether, artemether, artesunate, artemisia annua, bacteria, fungi, hydroxylations, synthetic reactions, molecular diversity, microbial generation.
Abstract: The biotransformations of artemisinin and artemisinin derivatives leading to metabolites that may serve as prospective candidates for antimalarial evaluation or as starting materials for hemisynthesis of antimalarial derivatives are reviewed, focusing on the preparation of regio- and stereoselectively hydroxylated derivatives still possessing the 1,2,4- trioxane structure that can be used as scaffolds for the production of novel antimalarials with increased water solubility, lower toxicity and decreased potential for resistance. A special emphasis has been also placed on the recent manufacturing of artemisinin and derivatives via microbiological methods, involving cloning and overexpression of biosynthetic enzymes and allowing to design an alternative route for artemisinin production.
Export Options
About this article
Cite this article as:
Azerad Robert, Microbial Transformations of Artemisinin and Artemisinin Derivatives: an Example of the Microbial Generation of Molecular Diversity, Current Bioactive Compounds 2012; 8 (2) . https://dx.doi.org/10.2174/157340712801784750
DOI https://dx.doi.org/10.2174/157340712801784750 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Fork Head Transcription Factors
Current Genomics Mouse Strains for Prostate Tumorigenesis Based on Genes Altered in Human Prostate Cancer
Current Drug Targets Pancreatic Cancer in Obesity: Epidemiology, Clinical Observations, and Basic Mechanisms
Anti-Cancer Agents in Medicinal Chemistry Cancer Chemoprevention with Green Tea Catechins: From Bench to Bed
Current Drug Targets Circulating Tumor Cells: A New Window for Diagnosis and Evaluation of Cancer
Anti-Cancer Agents in Medicinal Chemistry Gene Sets of Gene Ontology are More Stable Diagnostic Biomarkers than Genes in Oral Squamous Cell Carcinoma
Current Bioinformatics A Review on Advances in Organoborane-Chemistry: Versatile Tool in Asymmetric Synthesis
Current Organic Synthesis Stable Expression of the Sodium/Iodide Symporter (NIS) for anti-Cancer Gene Therapy of Glioma Cells Using a Third Generation Self-Inactivating Lentiviral Vector System in Combination with 211At
Current Radiopharmaceuticals Mitochondria-Associated Membranes (MAMs): A Novel Therapeutic Target for Treating Metabolic Syndrome
Current Medicinal Chemistry A Review on the Monoacylglycerol Lipase: At the Interface Between Fat and Endocannabinoid Signalling
Current Medicinal Chemistry The Mechanism of Calcitriol in Cancer Prevention and Treatment
Current Medicinal Chemistry Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The HGF-Met Signaling Axis: Emerging Themes and Targets of Inhibition
Current Protein & Peptide Science Low Testosterone and Diabetes
Current Diabetes Reviews Inflammasome, Inflammation and Cancer: An Interrelated Pathobiological Triad
Current Drug Targets Ligustrazine Suppresses the Growth of HRPC Cells through the Inhibition of Cap- Dependent Translation Via Both the mTOR and the MEK/ERK Pathways
Anti-Cancer Agents in Medicinal Chemistry Pharma-metabolomics in Neonatology: is it a Dream or a Fact?
Current Pharmaceutical Design The Use of Cytokines and Chemokines in the Cancer Immunotherapy
Recent Patents on Anti-Cancer Drug Discovery The Impact of the Emerging Genomics Data on the Management of Agerelated Phenotypes in the Context of Cellular Senescence
Current Drug Targets Synthesis of Unsymmetrical C5-Curcuminoids as Potential Anticancer Agents
Letters in Drug Design & Discovery